XML 14 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION (Tables)
9 Months Ended
Sep. 30, 2014
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
Supplemental Consolidating Balance Sheet Information
CONSOLIDATING BALANCE SHEETS
September 30, 2014
(In thousands)

Assets
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Current assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
95,245

 
$

 
$
27,974

 
$
2,469

 
$
(1,998
)
 
$
123,690

Receivables:
 
 
 
 
 
 
 
 
 
 
 
 
Trade
 

 
12,173

 
126,606

 

 

 
138,779

Loan and lease receivable
 

 

 
10,332

 

 

 
10,332

Contractual third-party reclamation receivables
 

 

 
7,666

 

 

 
7,666

Intercompany receivable/payable
 
195

 

 
376

 
(19,513
)
 
18,942

 

Other
 
1,856

 

 
570

 
59

 
(48
)
 
2,437

 
 
2,051

 
12,173

 
145,550

 
(19,454
)
 
18,894

 
159,214

Inventories
 

 
3,425

 
110,800

 

 

 
114,225

Deferred income taxes
 
5,455

 

 
865

 

 
(4,094
)
 
2,226

Other current assets
 
926

 
640

 
11,423

 
1,613

 

 
14,602

Total current assets
 
103,677

 
16,238

 
296,612

 
(15,372
)
 
12,802

 
413,957

Property, plant and equipment:
 
 
 
 
 
 
 
 
 
 
 
 
Land and mineral rights
 

 
1,395

 
443,306

 

 

 
444,701

Plant and equipment
 
4,022

 
221,530

 
576,415

 

 

 
801,967

 
 
4,022

 
222,925

 
1,019,721

 

 

 
1,246,668

Less accumulated depreciation, depletion and amortization
 
2,933

 
79,165

 
421,831

 

 

 
503,929

Net property, plant and equipment
 
1,089

 
143,760

 
597,890

 

 

 
742,739

Loan and lease receivables
 

 

 
76,080

 

 

 
76,080

Advanced coal royalties
 

 

 
7,533

 

 

 
7,533

Reclamation deposits
 

 

 
77,131

 

 

 
77,131

Restricted investments and bond collateral
 
63,602

 
3,400

 
41,732

 

 

 
108,734

Contractual third-party reclamation receivables
 

 

 
90,248

 

 

 
90,248

Investment in joint venture
 

 

 
30,766

 

 

 
30,766

Intangible assets
 

 
129

 
206

 

 

 
335

Investment in subsidiaries
 
337,967

 

 
10,333

 
3,770

 
(352,070
)
 

Intercompany receivable/payable
 
171,304

 

 
(171,304
)
 

 

 

Other assets
 
21,277

 

 
9,708

 
3,500

 
(3,500
)
 
30,985

Total assets
 
$
698,916

 
$
163,527

 
$
1,066,935

 
$
(8,102
)
 
$
(342,768
)
 
$
1,578,508

CONSOLIDATING BALANCE SHEETS
September 30, 2014
(In thousands)
Liabilities and Shareholders’ Deficit
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Current liabilities
 
 
 
 
 
 
 
 
 
 
 
 
Current installments of long-term debt
 
$

 
$

 
$
40,931

 
$

 
$

 
$
40,931

Accounts payable and accrued expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Trade and other accrued liabilities
 
6,167

 
7,964

 
126,754

 
63

 
(2
)
 
140,946

Interest payable
 
12,166

 

 
392

 
(1
)
 
(47
)
 
12,510

Production taxes
 

 
2

 
48,440

 
1,985

 

 
50,427

Workers’ compensation
 
702

 

 

 

 

 
702

Postretirement medical benefits
 
12,042

 

 
773

 
1,139

 
1

 
13,955

SERP
 
390

 

 

 

 

 
390

Deferred revenue
 

 
9,581

 
3,973

 

 

 
13,554

Asset retirement obligations
 

 

 
29,529

 

 

 
29,529

Intercompany receivable/payable
 

 

 
13,664

 

 
(13,664
)
 

Other current liabilities
 
1,080

 
5,099

 
5,596

 

 
(2,000
)
 
9,775

Total current liabilities
 
32,547

 
22,646

 
270,052

 
3,186

 
(15,712
)
 
312,719

Long-term debt, less current installments
 
696,833

 

 
84,666

 

 
(3,500
)
 
777,999

Workers’ compensation, less current portion
 
6,580

 

 

 

 

 
6,580

Excess of black lung benefit obligation over trust assets
 
10,768

 

 

 

 

 
10,768

Postretirement medical benefits, less current portion
 
184,323

 

 
70,113

 
18,087

 

 
272,523

Pension and SERP obligations, less current portion
 
12,634

 
96

 
7,805

 
237

 

 
20,772

Deferred revenue, less current portion
 

 
33,573

 
4,411

 

 

 
37,984

Asset retirement obligations, less current portion
 

 
944

 
354,335

 
(1
)
 

 
355,278

Intangible liabilities
 

 
4,805

 

 

 

 
4,805

Deferred income taxes
 
5,455

 

 
6,870

 

 

 
12,325

Other liabilities
 
707

 
25,415

 
3,167

 
1,797

 

 
31,086

Intercompany receivable/payable
 
13,400

 

 
(12,052
)
 
14,654

 
(16,002
)
 

Total liabilities
 
963,247

 
87,479

 
789,367

 
37,960

 
(35,214
)
 
1,842,839

Shareholders’ deficit
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock
 
92

 

 

 

 

 
92

Common stock
 
42,649

 
5

 
10,379

 
132

 
(10,516
)
 
42,649

Other paid-in capital
 
188,214

 
52,855

 
373,650

 
(124
)
 
(426,381
)
 
188,214

Advances to Parent
 

 
8,530

 
(24,334
)
 

 
15,804

 

Accumulated other comprehensive loss
 
(67,520
)
 
(158
)
 
3,068

 
(3,058
)
 
148

 
(67,520
)
Accumulated earnings (deficit)
 
(427,766
)
 
14,816

 
(85,195
)
 
(43,012
)
 
113,391

 
(427,766
)
Total equity (deficit)
 
(264,331
)
 
76,048

 
277,568

 
(46,062
)
 
(307,554
)
 
(264,331
)
Total liabilities and shareholders’ deficit
 
$
698,916

 
$
163,527

 
$
1,066,935

 
$
(8,102
)
 
$
(342,768
)
 
$
1,578,508

CONSOLIDATING BALANCE SHEETS
December 31, 2013
(In thousands)

Assets
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Current assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
25,326

 
$
3,341

 
$
27,451

 
$
4,992

 
$

 
$
61,110

Receivables:
 
 
 
 
 
 
 
 
 
 
 
 
Trade
 

 
12,934

 
46,985

 
6,277

 

 
66,196

Contractual third-party reclamation receivables
 

 

 
8,487

 

 

 
8,487

Intercompany receivable/payable
 
(16,273
)
 

 
2,761

 
(19,353
)
 
32,865

 

Other
 
1,616

 
210

 
3,256

 
28

 
(24
)
 
5,086

 
 
(14,657
)
 
13,144

 
61,489

 
(13,048
)
 
32,841

 
79,769

Inventories
 

 
6,161

 
33,811

 

 

 
39,972

Deferred income taxes
 
5,355

 

 
870

 

 
(870
)
 
5,355

Restricted investments and bond collateral
 

 
5,998

 

 

 

 
5,998

Other current assets
 
789

 
143

 
11,069

 
834

 

 
12,835

Total current assets
 
16,813

 
28,787

 
134,690

 
(7,222
)
 
31,971

 
205,039

Property, plant and equipment:
 
 
 
 
 
 
 
 
 
 
 
 
Land and mineral rights
 

 
1,395

 
276,793

 

 

 
278,188

Plant and equipment
 
3,973

 
220,872

 
432,851

 

 

 
657,696

 
 
3,973

 
222,267

 
709,644

 

 

 
935,884

Less accumulated depreciation, depletion and amortization
 
2,707

 
71,653

 
371,488

 

 

 
445,848

Net property, plant and equipment
 
1,266

 
150,614

 
338,156

 

 

 
490,036

Advanced coal royalties
 

 

 
7,311

 

 

 
7,311

Reclamation deposits
 

 

 
74,921

 

 

 
74,921

Restricted investments and bond collateral
 
15,134

 

 
54,101

 

 

 
69,235

Contractual third-party reclamation receivables
 

 

 
88,303

 

 

 
88,303

Intangible assets
 

 
1,283

 
237

 

 

 
1,520

Investment in subsidiaries
 
280,843

 

 

 
3,770

 
(284,613
)
 

Other assets
 
8,636

 

 
1,683

 
2,000

 
(1,999
)
 
10,320

Total assets
 
$
322,692

 
$
180,684

 
$
699,402

 
$
(1,452
)
 
$
(254,641
)
 
$
946,685

CONSOLIDATING BALANCE SHEETS
December 31, 2013
(In thousands)

Liabilities and Shareholders’ Deficit
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Current liabilities
 
 
 
 
 
 
 
 
 
 
 
 
Current installments of long-term debt
 
$
20,392

 
$

 
$
23,951

 
$

 
$

 
$
44,343

Accounts payable and accrued expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Trade
 
6,840

 
10,119

 
38,061

 
2,487

 

 
57,507

Interest payable
 
11,302

 

 
40

 

 
(21
)
 
11,321

Production taxes
 

 
3

 
36,522

 
5,380

 

 
41,905

Workers’ compensation
 
717

 

 

 

 

 
717

Postretirement medical benefits
 
12,042

 

 
774

 
1,139

 

 
13,955

SERP
 
390

 

 

 

 

 
390

Deferred revenue
 

 
9,024

 
5,044

 

 

 
14,068

Asset retirement obligations
 

 

 
23,353

 

 

 
23,353

Other current liabilities
 

 
5,053

 
417

 

 
(1
)
 
5,469

Total current liabilities
 
51,683

 
24,199

 
128,162

 
9,006

 
(22
)
 
213,028

Long-term debt, less current installments
 
224,582

 

 
72,912

 

 
(2,000
)
 
295,494

Workers’ compensation, less current portion
 
6,744

 

 

 

 

 
6,744

Excess of black lung benefit obligation over trust assets
 
8,675

 

 

 

 

 
8,675

Postretirement medical benefits, less current portion
 
185,858

 

 
66,439

 
18,077

 

 
270,374

Pension and SERP obligations, less current portion
 
13,069

 
99

 
10,765

 
243

 

 
24,176

Deferred revenue, less current portion
 

 
41,297

 
5,270

 

 

 
46,567

Asset retirement obligations, less current portion
 

 
892

 
255,619

 

 

 
256,511

Intangible liabilities
 

 
5,606

 

 

 

 
5,606

Deferred income taxes
 
5,355

 

 

 

 

 
5,355

Other liabilities
 
584

 

 
6,687

 
983

 
(6,220
)
 
2,034

Intercompany receivable/payable
 
14,021

 

 
(7,851
)
 
14,654

 
(20,824
)
 

Total liabilities
 
510,571

 
72,093

 
538,003

 
42,963

 
(29,066
)
 
1,134,564

Shareholders’ deficit
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock
 
160

 

 

 

 

 
160

Common stock
 
36,479

 
5

 
110

 
132

 
(247
)
 
36,479

Other paid-in capital
 
134,861

 
52,835

 
157,984

 
(124
)
 
(210,695
)
 
134,861

Accumulated other comprehensive loss
 
(63,595
)
 
(164
)
 
6,425

 
(3,086
)
 
(3,175
)
 
(63,595
)
Accumulated earnings (deficit)
 
(295,784
)
 
55,915

 
(3,120
)
 
(41,337
)
 
(11,458
)
 
(295,784
)
Total equity (deficit)
 
(187,879
)
 
108,591

 
161,399

 
(44,415
)
 
(225,575
)
 
(187,879
)
Total liabilities and shareholders’ deficit
 
$
322,692

 
$
180,684

 
$
699,402

 
$
(1,452
)
 
$
(254,641
)
 
$
946,685

Supplemental Consolidating Statement of Operations Information
CONSOLIDATING STATEMENTS OF OPERATIONS
Three Months Ended September 30, 2014
(In thousands)
 
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Revenues
$

 
$
21,439

 
$
316,391

 
$

 
$

 
$
337,830

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
(1,037
)
 
20,799

 
265,762

 

 

 
285,524

Depreciation, depletion and amortization
70

 
2,503

 
25,602

 

 

 
28,175

Selling and administrative
5,124

 
899

 
18,834

 
(423
)
 

 
24,434

Heritage health benefit expenses
3,099

 

 

 
216

 

 
3,315

Loss on sales of assets

 

 
119

 

 

 
119

Restructuring charges
663

 
(39
)
 
2,641

 

 

 
3,265

Unrealized derivative loss

 
23,691

 

 

 

 
23,691

Income from equity affiliates

 

 
(1,261
)
 

 

 
(1,261
)
 
7,919

 
47,853

 
311,697

 
(207
)
 

 
367,262

Operating income (loss)
(7,919
)
 
(26,414
)
 
4,694

 
207

 

 
(29,432
)
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest expense
(18,302
)
 
(102
)
 
(10,614
)
 

 
7,767

 
(21,251
)
Loss on extinguishment of debt

 

 
(13
)
 

 

 
(13
)
Interest income
7,891

 
1

 
2,343

 

 
(7,767
)
 
2,468

Loss on foreign exchange
(148
)
 

 
(1,594
)
 

 

 
(1,742
)
Other income
5

 

 
113

 

 

 
118

 
(10,554
)
 
(101
)
 
(9,765
)
 

 

 
(20,420
)
Income (loss) before income taxes and income of consolidated subsidiaries
(18,473
)
 
(26,515
)
 
(5,071
)
 
207

 

 
(49,852
)
Equity in income of subsidiaries
(31,128
)
 

 

 

 
31,128

 

Income (loss) before income taxes
(49,601
)
 
(26,515
)
 
(5,071
)
 
207

 
31,128

 
(49,852
)
Income tax expense (benefit)
(467
)
 

 
3,362

 
1

 
(3,614
)
 
(718
)
Net income (loss)
(49,134
)
 
(26,515
)
 
(8,433
)
 
206

 
34,742

 
(49,134
)
Less net loss attributable to noncontrolling interest

 

 

 

 

 

Net income (loss) attributable to the Parent company
$
(49,134
)
 
$
(26,515
)
 
$
(8,433
)
 
$
206

 
$
34,742

 
$
(49,134
)

CONSOLIDATING STATEMENTS OF OPERATIONS
Three Months Ended September 30, 2013
(In thousands)

 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Revenues
$

 
$
24,911

 
$
149,079

 
$
17,149

 
$
(14,347
)
 
$
176,792

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
(371
)
 
16,366

 
115,587

 
20,958

 
(14,347
)
 
138,193

Depreciation, depletion and amortization
93

 
2,551

 
14,791

 

 
(1
)
 
17,434

Selling and administrative
4,191

 
907

 
7,867

 
(467
)
 

 
12,498

Heritage health benefit expenses
3,789

 

 

 
268

 

 
4,057

Gain on sales of assets

 

 
(13
)
 

 

 
(13
)
Other operating income

 

 
(3,913
)
 

 

 
(3,913
)
 
7,702

 
19,824

 
134,319

 
20,759

 
(14,348
)
 
168,256

Operating income (loss)
(7,702
)
 
5,087

 
14,760

 
(3,610
)
 
1

 
8,536

Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest expense
(7,622
)
 
(10
)
 
(2,281
)
 
(2
)
 
6

 
(9,909
)
Loss on extinguishment of debt

 

 

 

 

 

Interest income
29

 
5

 
267

 
6

 
(6
)
 
301

Other income (loss)

 

 
89

 

 

 
89

 
(7,593
)
 
(5
)
 
(1,925
)
 
4

 

 
(9,519
)
Income (loss) before income taxes and income of consolidated subsidiaries
(15,295
)
 
5,082

 
12,835

 
(3,606
)
 
1

 
(983
)
Equity in income of subsidiaries
14,281

 

 

 

 
(14,281
)
 

Income (loss) before income taxes
(1,014
)
 
5,082

 
12,835

 
(3,606
)
 
(14,280
)
 
(983
)
Income tax expense (benefit)
(1
)
 

 
1,742

 
1

 
(1,712
)
 
30

Net income (loss)
(1,013
)
 
5,082

 
11,093

 
(3,607
)
 
(12,568
)
 
(1,013
)
Less net loss attributable to noncontrolling interest
(3,774
)
 

 

 

 

 
(3,774
)
Net income (loss) attributable to the Parent company
$
2,761

 
$
5,082

 
$
11,093

 
$
(3,607
)
 
$
(12,568
)
 
$
2,761


CONSOLIDATING STATEMENTS OF OPERATIONS
Nine Months Ended September 30, 2014
(In thousands)
 
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Revenues
$

 
$
65,254

 
$
740,742

 
$
(7
)
 
$

 
$
805,989

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
(1,508
)
 
58,845

 
613,075

 
55

 

 
670,467

Depreciation, depletion and amortization
225

 
7,513

 
60,975

 

 

 
68,713

Selling and administrative
22,092

 
2,961

 
44,694

 
(1,196
)
 

 
68,551

Heritage health benefit expenses
9,602

 

 

 
644

 

 
10,246

Loss on sales of assets

 

 
114

 

 

 
114

Restructuring charges
1,460

 
459

 
9,288

 

 

 
11,207

Unrealized derivative loss

 
29,621

 

 

 

 
29,621

Equity in net income of unconsolidated affiliates

 

 
(2,060
)
 

 

 
(2,060
)
Other operating income

 

 
150

 
1

 

 
151

 
31,871

 
99,399

 
726,236

 
(496
)
 

 
857,010

Operating income (loss)
(31,871
)
 
(34,145
)
 
14,506

 
489

 

 
(51,021
)
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest expense
(55,584
)
 
(220
)
 
(15,813
)
 

 
7,782

 
(63,835
)
Loss on extinguishment of debt
(64
)
 

 
(12,584
)
 

 

 
(12,648
)
Interest income
8,160

 
8

 
3,941

 
24

 
(7,782
)
 
4,351

Loss on foreign exchange
(5,382
)
 

 
(501
)
 

 

 
(5,883
)
Other income
7

 

 
691

 
(1
)
 

 
697

 
(52,863
)
 
(212
)
 
(24,266
)
 
23

 

 
(77,318
)
Income (loss) before income taxes and income of consolidated subsidiaries
(84,734
)
 
(34,357
)
 
(9,760
)
 
512

 

 
(128,339
)
Equity in income of subsidiaries
(47,274
)
 

 

 

 
47,274

 

Income (loss) before income taxes
(132,008
)
 
(34,357
)
 
(9,760
)
 
512

 
47,274

 
(128,339
)
Income tax expense (benefit)
(690
)
 

 
2,244

 

 
1,425

 
2,979

Net income (loss)
(131,318
)
 
(34,357
)
 
(12,004
)
 
512

 
45,849

 
(131,318
)
Less net loss attributable to noncontrolling interest

 

 

 

 

 

Net income (loss) attributable to the Parent company
$
(131,318
)
 
$
(34,357
)
 
$
(12,004
)
 
$
512

 
$
45,849

 
$
(131,318
)


CONSOLIDATING STATEMENTS OF OPERATIONS
Nine Months Ended September 30, 2013
(In thousands)

 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Revenues
$

 
$
67,409

 
$
423,266

 
$
38,037

 
$
(27,973
)
 
$
500,739

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales
(1,141
)
 
48,221

 
339,004

 
41,031

 
(27,973
)
 
399,142

Depreciation, depletion and amortization
280

 
7,632

 
39,345

 

 

 
47,257

Selling and administrative
12,399

 
2,633

 
22,547

 
(1,225
)
 

 
36,354

Heritage health benefit expenses
10,322

 

 

 
795

 

 
11,117

Loss (gain) on sales of assets

 

 
(321
)
 

 

 
(321
)
Other operating income

 

 
(19,054
)
 
(1
)
 

 
(19,055
)
 
21,860

 
58,486

 
381,521

 
40,600

 
(27,973
)
 
474,494

Operating income (loss)
(21,860
)
 
8,923

 
41,745

 
(2,563
)
 

 
26,245

Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest expense
(22,797
)
 
(30
)
 
(7,329
)
 
(12
)
 
23

 
(30,145
)
Loss on extinguishment of debt
(64
)
 

 

 

 

 
(64
)
Interest income
105

 
20

 
760

 
16

 
(23
)
 
878

Other income (loss)

 

 
289

 
(2
)
 

 
287

 
(22,756
)
 
(10
)
 
(6,280
)
 
2

 

 
(29,044
)
Income (loss) before income taxes and income of consolidated subsidiaries
(44,616
)
 
8,913

 
35,465

 
(2,561
)
 

 
(2,799
)
Equity in income of subsidiaries
41,732

 

 

 

 
(41,732
)
 

Income (loss) before income taxes
(2,884
)
 
8,913

 
35,465

 
(2,561
)
 
(41,732
)
 
(2,799
)
Income tax expense (benefit)

 

 
6,200

 

 
(6,115
)
 
85

Net income (loss)
(2,884
)
 
8,913

 
29,265

 
(2,561
)
 
(35,617
)
 
(2,884
)
Less net loss attributable to noncontrolling interest
(2,976
)
 

 

 

 

 
(2,976
)
Net income (loss) attributable to the Parent company
$
92

 
$
8,913

 
$
29,265

 
$
(2,561
)
 
$
(35,617
)
 
$
92

Supplemental Consolidating Statements of Comprehensive Income (Loss)
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Three Months Ended September 30, 2014
(In thousands)
 
Parent/Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Net income (loss)
$
(49,134
)
 
$
(26,515
)
 
$
(8,433
)
 
$
206

 
$
34,742

 
$
(49,134
)
Other comprehensive income (loss)
 
 
 
 
 
 
 
 
 
 
 
Amortization of accumulated actuarial gains or losses, pension
361

 
(1
)
 
127

 
15

 
(141
)
 
361

Adjustments to accumulated actuarial losses and transition obligations, pension
(371
)
 

 
(371
)
 

 
371

 
(371
)
Amortization of accumulated actuarial gains or losses, transition obligations, and prior service costs, postretirement medical benefit
3

 

 
(322
)
 
8

 
314

 
3

Tax effect of other comprehensive income gains
(487
)
 

 

 

 

 
(487
)
Change in foreign currency translation adjustment
(14,642
)
 

 
(13,729
)
 

 
13,729

 
(14,642
)
Unrealized and realized gains and losses on available-for-sale securities
1,231

 

 
1,007

 

 
(1,007
)
 
1,231

Other comprehensive income (loss)
(13,905
)
 
(1
)
 
(13,288
)
 
23

 
13,266

 
(13,905
)
Comprehensive income (loss) attributable to the Parent company
$
(63,039
)
 
$
(26,516
)
 
$
(21,721
)
 
$
229

 
$
48,008

 
$
(63,039
)

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Three Months Ended September 30, 2013
(In thousands)
 
Parent/Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Net income (loss)
$
(1,013
)
 
$
5,082

 
$
11,093

 
$
(3,607
)
 
$
(12,568
)
 
$
(1,013
)
Other comprehensive income (loss)
 
 
 
 
 
 
 
 
 
 
 
Amortization of accumulated actuarial gains or losses, pension
872

 
7

 
601

 
(386
)
 
(222
)
 
872

Amortization of accumulated actuarial gains or losses, transition obligations, and prior service costs, postretirement medical benefit
1,002

 

 
433

 
(220
)
 
(213
)
 
1,002

Unrealized and realized gains and losses on available-for-sale securities
(16
)
 

 
(39
)
 
23

 
16

 
(16
)
Other comprehensive income (loss)
1,858

 
7

 
995

 
(583
)
 
(419
)
 
1,858

Comprehensive income (loss) attributable to the Parent company
$
845

 
$
5,089

 
$
12,088

 
$
(4,190
)
 
$
(12,987
)
 
$
845




CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Nine Months Ended September 30, 2014
(In thousands)
 
Parent/Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Net income (loss)
$
(131,318
)
 
$
(34,357
)
 
$
(12,004
)
 
$
512

 
$
45,849

 
$
(131,318
)
Other comprehensive income (loss)
 
 
 
 
 
 
 
 
 
 
 
Amortization of accumulated actuarial gains or losses, pension
1,078

 
7

 
366

 
15

 
(388
)
 
1,078

Adjustments to accumulated actuarial losses and transition obligations, pension
(172
)
 

 
(172
)
 

 
172

 
(172
)
Amortization of accumulated actuarial gains or losses, transition obligations, and prior service costs, postretirement medical benefit
13

 

 
(108
)
 
14

 
94

 
13

Tax effect of other comprehensive income gains
(711
)
 

 

 

 

 
(711
)
Change in foreign currency translation adjustment
(5,364
)
 

 
(4,451
)
 

 
4,451

 
(5,364
)
Unrealized and realized gains and losses on available-for-sale securities
1,231

 

 
1,007

 

 
(1,007
)
 
1,231

Other comprehensive income (loss)
(3,925
)
 
7

 
(3,358
)
 
29

 
3,322

 
(3,925
)
Comprehensive income (loss) attributable to the Parent company
$
(135,243
)
 
$
(34,350
)
 
$
(15,362
)
 
$
541

 
$
49,171

 
$
(135,243
)




CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Nine Months Ended September 30, 2013
(In thousands)
 
Parent/Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Net income (loss)
$
(2,884
)
 
$
8,913

 
$
29,265

 
$
(2,561
)
 
$
(35,617
)
 
$
(2,884
)
Other comprehensive income (loss)
 
 
 
 
 
 
 
 
 
 
 
Amortization of accumulated actuarial gains or losses, pension
2,617

 
21

 
601

 
47

 
(669
)
 
2,617

Amortization of accumulated actuarial gains or losses, transition obligations, and prior service costs, postretirement medical benefit
3,004

 

 
433

 
207

 
(640
)
 
3,004

Unrealized and realized gains and losses on available-for-sale securities
(55
)
 

 
(56
)
 
1

 
55

 
(55
)
Other comprehensive income (loss)
5,566

 
21

 
978

 
255

 
(1,254
)
 
5,566

Comprehensive income (loss) attributable to the Parent company
$
2,682

 
$
8,934

 
$
30,243

 
$
(2,306
)
 
$
(36,871
)
 
$
2,682


Supplemental Consolidating Statement of Cash Flow Information
CONSOLIDATING STATEMENTS OF CASH FLOWS
Nine Months Ended September 30, 2014
(In thousands)

Statements of Cash Flows
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
(131,318
)
 
$
(34,357
)
 
$
(12,004
)
 
$
512

 
$
45,849

 
$
(131,318
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
Equity in income of subsidiaries
 
47,274

 

 

 

 
(47,274
)
 

Depreciation, depletion, and amortization
 
225

 
7,513

 
60,975

 

 

 
68,713

Accretion of asset retirement obligation and receivable
 

 
51

 
16,206

 

 

 
16,257

Non-cash tax benefits
 
(711
)
 

 

 

 

 
(711
)
Amortization of intangible assets and liabilities, net
 

 
354

 
31

 

 

 
385

Share-based compensation
 
2,256

 
20

 
1,180

 

 

 
3,456

Gain on sales of assets
 

 

 
114

 

 

 
114

Amortization of deferred financing costs
 
620

 

 
1,745

 

 

 
2,365

Loss on extinguishment of debt
 
64

 

 
12,584

 

 

 
12,648

Loss on sales of investment securities
 

 

 
36

 

 

 
36

Unrealized loss on derivative
 

 
29,621

 

 

 

 
29,621

Loss on foreign exchange
 
5,382

 

 
501

 

 

 
5,883

Pension settlement accounting
 

 

 
814

 

 

 
814

Income from equity affiliates
 

 

 
(2,060
)
 

 

 
(2,060
)
Distributions from equity affiliates
 

 

 
2,948

 

 

 
2,948

Changes in operating assets and liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Receivables, net
 
(240
)
 
971

 
(31,512
)
 
4,719

 
1,542

 
(24,520
)
Inventories
 

 
2,736

 
52,663

 

 

 
55,399

Excess of black lung benefit obligation over trust assets
 
2,093

 

 

 

 

 
2,093

Deferred income tax
 

 

 
(750
)
 

 
4,094

 
3,344

Accounts payable and accrued expenses
 
126

 
(2,264
)
 
14,361

 
(5,820
)
 
(26
)
 
6,377

Deferred revenue
 

 
(7,167
)
 
(1,973
)
 

 

 
(9,140
)
Income tax payable
 

 

 
556

 

 

 
556

Accrual for workers’ compensation
 
(179
)
 

 
1

 

 

 
(178
)
Asset retirement obligations
 

 

 
(5,882
)
 
1

 

 
(5,881
)
Accrual for postretirement medical benefits
 
(1,428
)
 

 
3,567

 
24

 

 
2,163

Pension and SERP obligations
 
256

 
4

 
(1,273
)
 
9

 

 
(1,004
)
Other assets and liabilities
 
(7,996
)
 
(5,282
)
 
7,849

 
(1,299
)
 
6,579

 
(149
)
Distributions received from subsidiaries
 
92,100

 

 

 

 
(92,100
)
 

Net cash provided by (used in) operating activities
 
8,524

 
(7,800
)
 
120,677

 
(1,854
)
 
(81,336
)
 
38,211

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Additions to property, plant and equipment
 
16

 
(419
)
 
(35,244
)
 
1

 

 
(35,646
)
Change in restricted investments and bond collateral and reclamation deposits
 
(48,244
)
 
2,598

 
3,851

 

 

 
(41,795
)
Cash payments related to Canadian acquisition
 
(282,788
)
 

 
(39,849
)
 

 

 
(322,637
)
Cash acquired related to Canadian acquisition
 

 

 
8,103

 

 

 
8,103

Net proceeds from sales of assets
 

 

 
38,085

 

 

 
38,085

Proceeds from the sale of investments
 

 

 
7,279

 

 

 
7,279

Increase in loan and lease receivables
 

 

 
(2,514
)
 

 

 
(2,514
)
Receipts from loan and lease receivables
 

 

 
5,057

 

 

 
5,057

Receivable from customer for property and equipment purchases
 

 

 
55

 

 

 
55

Investment of common shares
 
(2,992
)
 

 
2,992

 

 

 

Other
 

 

 
(602
)
 

 

 
(602
)
Net cash provided by (used in) investing activities
 
(334,008
)
 
2,179

 
(12,787
)
 
1

 

 
(344,615
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Change in book overdrafts
 

 
493

 
1,188

 

 
(1,998
)
 
(317
)
Borrowings from long-term debt
 
454,219

 

 

 

 

 
454,219

Repayments of long-term debt
 
(1,015
)
 

 
(109,777
)
 

 

 
(110,792
)
Borrowings on revolving lines of credit
 

 

 
15,000

 

 

 
15,000

Repayments on revolving lines of credit
 

 

 
(15,000
)
 

 

 
(15,000
)
Debt issuance costs and other refinancing costs
 
(16,168
)
 

 
(11,659
)
 

 

 
(27,827
)
Dividends/distributions
 
(664
)
 
(8,500
)
 
(83,600
)
 

 
92,100

 
(664
)
Proceeds from issuance of common shares
 
56,473

 

 

 

 

 
56,473

Exercise of stock options
 
417

 

 

 

 

 
417

Transactions with Parent/affiliates
 
(97,859
)
 
10,287

 
99,006

 
(670
)
 
(10,764
)
 

Net cash provided by (used in) financing activities
 
395,403

 
2,280

 
(104,842
)
 
(670
)
 
79,338

 
371,509

Effect of foreign exchange rates on cash
 

 

 
(2,525
)
 

 

 
(2,525
)
Net decrease in cash and cash equivalents
 
69,919

 
(3,341
)
 
523

 
(2,523
)
 
(1,998
)
 
62,580

Cash and cash equivalents, beginning of period
 
25,326

 
3,341

 
27,451

 
4,992

 

 
61,110

Cash and cash equivalents, end of period
 
$
95,245

 
$

 
$
27,974

 
$
2,469

 
$
(1,998
)
 
$
123,690

CONSOLIDATING STATEMENTS OF CASH FLOWS
Nine Months Ended September 30, 2013
(In thousands)

Statements of Cash Flows
 
Parent/
Issuer
 
Co-Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Total
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
(2,884
)
 
$
8,913

 
$
29,265

 
$
(2,561
)
 
$
(35,617
)
 
$
(2,884
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
Equity in income of subsidiaries
 
(41,732
)
 

 

 

 
41,732

 

Depreciation, depletion, and amortization
 
280

 
7,632

 
39,345

 

 

 
47,257

Accretion of asset retirement obligation and receivable
 

 
48

 
9,460

 
(1
)
 

 
9,507

Amortization of intangible assets and liabilities, net
 

 
467

 
32

 
(1
)
 

 
498

Share-based compensation
 
2,233

 
30

 
2,333

 
(2
)
 

 
4,594

Gain on sales of assets
 

 

 
(321
)
 

 

 
(321
)
Amortization of deferred financing costs
 
2,353

 

 
441

 
(4
)
 

 
2,790

Loss on extinguishment of debt
 
64

 

 

 

 

 
64

Loss on sales of investment securities
 

 

 
(26
)
 
1

 

 
(25
)
Changes in operating assets and liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Receivables, net
 
(652
)
 
(1,651
)
 
(7,426
)
 
(3,248
)
 
4,486

 
(8,491
)
Inventories
 

 
(1,020
)
 
(580
)
 

 

 
(1,600
)
Excess of black lung benefit obligation over trust assets
 
53

 

 

 

 

 
53

Accounts payable and accrued expenses
 
(8,157
)
 
4,314

 
14,783

 
4,472

 
(2,955
)
 
12,457

Deferred revenue
 

 
(6,608
)
 
(1,667
)
 

 

 
(8,275
)
Income tax payable
 

 

 
(26
)
 

 

 
(26
)
Accrual for workers’ compensation
 
(359
)
 

 

 

 

 
(359
)
Asset retirement obligations
 

 

 
(6,887
)
 
(1
)
 

 
(6,888
)
Accrual for postretirement medical benefits
 
118

 

 
5,624

 
288

 

 
6,030

Pension and SERP obligations
 
1,041

 
13

 
1,191

 
28

 

 
2,273

Other assets and liabilities
 
(240
)
 
(453
)
 
2,971

 
(464
)
 
1

 
1,815

Distributions received from subsidiaries
 
50,800

 

 

 

 
(50,800
)
 

Net cash provided by (used in) operating activities
 
2,918

 
11,685

 
88,512

 
(1,493
)
 
(43,153
)
 
58,469

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Additions to property, plant and equipment
 
(520
)
 
(715
)
 
(18,985
)
 
(3
)
 

 
(20,223
)
Change in restricted investments and bond collateral and reclamation deposits
 
91

 
(6
)
 
(9,735
)
 
(2
)
 

 
(9,652
)
Net proceeds from sales of assets
 

 

 
604

 

 

 
604

Proceeds from the sale of investments
 

 

 
7,927

 

 

 
7,927

Receivable from customer for property and equipment purchases
 

 

 
(1
)
 

 

 
(1
)
Net cash used in investing activities
 
(429
)
 
(721
)
 
(20,190
)
 
(5
)
 

 
(21,345
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Change in book overdrafts
 

 

 
20

 

 

 
20

Repayments of long-term debt
 
(500
)
 

 
(21,558
)
 
(7
)
 

 
(22,065
)
Borrowings on revolving lines of credit
 

 

 
7,000

 

 

 
7,000

Repayments on revolving lines of credit
 

 

 
(7,000
)
 

 

 
(7,000
)
Debt issuance costs and other refinancing costs
 
(26
)
 

 
(156
)
 

 

 
(182
)
Dividends/distributions
 
(1,020
)
 
(14,500
)
 
(23,500
)
 
(12,800
)
 
50,800

 
(1,020
)
Transactions with Parent/affiliates
 
(7,132
)
 
(102
)
 
(307
)
 
15,188

 
(7,647
)
 

Net cash provided by (used in) financing activities
 
(8,678
)
 
(14,602
)
 
(45,501
)
 
2,381

 
43,153

 
(23,247
)
Net increase (decrease) in cash and cash equivalents
 
(6,189
)
 
(3,638
)
 
22,821

 
883

 

 
13,877

Cash and cash equivalents, beginning of period
 
14,836

 
4,545

 
10,237

 
1,992

 

 
31,610

Cash and cash equivalents, end of period
 
$
8,647

 
$
907

 
$
33,058

 
$
2,875

 
$

 
$
45,487